Literature DB >> 27009813

Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.

Neda Razaz1,2, Helen Tremlett3,4, Thomas Boyce5, Martin Guhn1, Ruth Ann Marrie6, K S Joseph1,2.   

Abstract

BACKGROUND: Although parental multiple sclerosis (MS) may put children at increased risk for mental health disorders such as anxiety and depression, the incidence and determinants of such disorders have not been examined.
METHOD: We carried out a retrospective cohort study in British Columbia, Canada, among children of parents with MS and age-matched children of unaffected parents. Cox regression was used to estimate the association between parental MS and mood or anxiety disorders in children.
RESULTS: The study included 1028 children of MS parents, 4010 children of unaffected parents, and 25 464 child-years of follow-up (median follow-up of 4 years). Mental health morbidity was more common among MS parents vs. unaffected parents (50.4% vs. 33.1%) and among MS-affected mothers vs. unaffected mothers (54.6% vs. 38.0%, P < 0.001). The incidence of child mood or anxiety disorders was 8.3 and 6.3 per 1000 child-years among children of parents with and without MS respectively. Sex of the MS-affected parent modified the relationship between parental MS and mood or anxiety disorders in children (P = 0.04). Compared with children of unaffected mothers, children of mothers affected by MS had higher rates of mood or anxiety disorders (HR 1.7, 95% CI 1.1, 2.4), whereas children of MS-affected fathers did not (HR 0.5, 95% CI 0.2, 1.7). Adjustment for mental health morbidity in mothers diminished the association between maternal MS and child mood or anxiety disorders.
CONCLUSION: Maternal MS is associated with a higher rate of mood or anxiety disorders in children and this association appeared to be mediated by maternal mental health morbidity.
© 2016 The Authors Paediatric and Perinatal Epidemiology Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Child psychiatry; Cohort studies; Maternal Depression; Multiple sclerosis; Pediatric depression; Population-based studies; administrative databases

Mesh:

Year:  2016        PMID: 27009813     DOI: 10.1111/ppe.12290

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  6 in total

1.  Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children.

Authors:  Neda Razaz; Helen Tremlett; Ruth Ann Marrie; K S Joseph
Journal:  Mult Scler       Date:  2016-02-22       Impact factor: 6.312

2.  Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health.

Authors:  Neda Razaz; K S Joseph; W Thomas Boyce; Martin Guhn; Barry Forer; Robert Carruthers; Ruth Ann Marrie; Helen Tremlett
Journal:  Mult Scler       Date:  2015-12-18       Impact factor: 6.312

Review 3.  Young People's Response to Parental Neurological Disorder: A Structured Review.

Authors:  Lilian Hartman; Crispin Jenkinson; David Morley
Journal:  Adolesc Health Med Ther       Date:  2020-03-26

4.  The impact of SARS-CoV2 on the anxiety levels of subjects and on the anxiety and depression levels of their parents.

Authors:  Tugce Damla Dilek; Zehra Boybay; Nursena Kologlu; Oguzhan Tin; Serhat Güler; Sema Saltık
Journal:  Mult Scler Relat Disord       Date:  2020-10-26       Impact factor: 4.339

5.  Mental health among children of mothers with multiple sclerosis: A Danish cohort and register-based study.

Authors:  Johanna Balslev Andersen; Julie Yoon Moberg; Janni Niclasen; Bjarne Laursen; Melinda Magyari
Journal:  Brain Behav       Date:  2018-09-21       Impact factor: 2.708

6.  Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study.

Authors:  Karine Eid; Øivind Fredvik Torkildsen; Jan Aarseth; Heidi Øyen Flemmen; Trygve Holmøy; Åslaug Rudjord Lorentzen; Kjell-Morten Myhr; Trond Riise; Cecilia Simonsen; Cecilie Fredvik Torkildsen; Stig Wergeland; Johannes Sverre Willumsen; Nina Øksendal; Nils Erik Gilhus; Marte-Helene Bjørk
Journal:  Neurology       Date:  2021-04-21       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.